Nemanja Damjanov

Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study

Josef S Smolen, Aileen L. Pangan, Paul Emery et al. · The Lancet · 2019 · 378 citations

Medicine, Pharmacology, Pharmacotherapy +10

The 2017 EULAR standardised procedures for ultrasound imaging in rheumatology

Ingrid Möller, I. Janta, Marina Backhaus et al. · Annals of the Rheumatic Diseases · 2017 · 293 citations

Medicine, Anatomy, Radiology +17

Efficacy, pharmacodynamics, and safety of VX‐702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: Results of two randomized, double‐blind, placebo‐controlled clinical studies

Nemanja Damjanov, Robert S. Kauffman, G Spencer-Green · Arthritis & Rheumatism · 2009 · 246 citations

Medicine, Pharmacology, Pharmacotherapy +10

Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double‐blind, methotrexate‐controlled study of patients with active rheumatoid arthritis

Stanley Cohen, Tien‐Tsai Cheng, Vishala Chindalore et al. · Arthritis & Rheumatism · 2009 · 231 citations

Medicine, Pharmacology, Pharmacotherapy +16

Safety and efficacy of an oral histone deacetylase inhibitor in systemic‐onset juvenile idiopathic arthritis

Jelena Vojinović, Nemanja Damjanov, Carmine D’Urzo et al. · Arthritis & Rheumatism · 2011 · 217 citations

Medicine, Clinical Sciences, Pharmacotherapy +14